Terumo (TSE: 4543) recently announced that it has signed a definitive agreement to acquire all assets of Health Outcomes Sciences.
The financial terms of the deal were not disclosed.
Phoenix-based HOS is a creator of predictive analytics and clinical decision support software. Its sePRISM content enablement platform is meant to enable healthcare organizations to deliver personalized, predictive, point-of-care insights.
“The acquisition of Health Outcomes Sciences and the ePrism platform expands Terumo’s presence in the digital healthcare arena and represents a compelling growth opportunity for our company,” said Toshi Osada, president of Tokyo-based Terumo’s Cardiac and Vascular Company.
“It further allows Terumo to deliver innovative digital solutions, providing healthcare systems with critical data needed to lower the cost of healthcare delivery while substantially improving patient outcomes,” Osada said in a Feb. 23 news release.